A pilot study on faecal MMP-9 a new noninvasive diagnostic marker of colorectal cancer /

BACKGROUND: Colorectal cancer (CRC) is one of the leading malignancies worldwide, therefore cheap noninvasive screening methods are of great importance. Matrix-metalloproteinase-9 (MMP-9) has a role in the progression of CRC, and its level is elevated in tumour biopsies. Faecal MMP-9 levels are inc...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Annaházi Anita
Ábrahám Szabolcs
Farkas Klaudia
Rosztóczy András
Inczefi Orsolya
Földesi Imre
Szűcs Mónika
Rutka Mariann
Theodorou Vassilia
Eutamene Helene
Bueno Lionel
Lázár György, ifj
Wittmann Tibor
Molnár Tamás
Róka Richárd László
Dokumentumtípus: Cikk
Megjelent: 2016
Sorozat:BRITISH JOURNAL OF CANCER 114 No. 7
doi:10.1038/bjc.2016.31

mtmt:3047642
Online Access:http://publicatio.bibl.u-szeged.hu/6747
Leíró adatok
Tartalmi kivonat:BACKGROUND: Colorectal cancer (CRC) is one of the leading malignancies worldwide, therefore cheap noninvasive screening methods are of great importance. Matrix-metalloproteinase-9 (MMP-9) has a role in the progression of CRC, and its level is elevated in tumour biopsies. Faecal MMP-9 levels are increased in active ulcerative colitis patients, but in CRC patients, they have never been measured. We aimed to assess the faecal MMP-9 levels in patients undergoing total colonoscopy according to endoscopic and histological diagnosis. METHODS: One hundred and nine patients provided faecal samples for MMP-9 analysis. A total colonoscopy was performed; suspicious lesions were evaluated by histology. Faecal MMP-9 levels were measured by ELISA. RESULTS: The number of patients allocated to different groups were: negative/diverticulosis: 34 (referred to as controls); hyperplastic polyps: 15; adenomas: 32 (22 at high risk); and CRC: 28. Faecal MMP-9 was significantly increased in CRC compared with all other groups (P<0.001). Faecal MMP-9 was suitable to distinguish CRC patients from controls (sensitivity: 89.3%; specificity: 91.2%). By means of a lower cutoff level, faecal MMP-9 identified high-risk adenomas besides CRC (sensitivity: 76%; specificity: 85.3%). This lower cutoff level screened 59% of high-risk adenomas. CONCLUSIONS: Faecal MMP-9 may be a promising new noninvasive marker in CRC.
Terjedelem/Fizikai jellemzők:787-792
ISSN:0007-0920